Jeffrey Craig

Jeffrey W. Craig, M.D., Ph.D., is an Assistant Professor of Pathology at the University of Virginia School of Medicine, a position he has held since 2021. He earned his M.D. from Weill Cornell Medical College and his Ph.D. from Rockefeller University, followed by residency and fellowship training in Anatomic and Clinical Pathology and Hematopathology at Brigham and Women’s Hospital. His research focuses on the diagnostic classification of lymphoid neoplasms, particularly T-cell malignancies, and hemato-oncology. Recent work explores synthetic lethality of MCL-1 inhibition with CAR-T therapy in aggressive B-cell lymphoma, CDK9 inhibitor efficacy, and nanoromidepsin, a polymer nanoparticle HDAC inhibitor for T-cell lymphoma. He holds broad international collaborations spanning institutions in Canada, Germany, France, Japan, and Singapore.